{
    "nctId": "NCT02209545",
    "officialTitle": "Buccal Misoprostol Prior to Abdominal Myomectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial",
    "inclusionCriteria": "* Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within in last 12 months\n* Age \u2265 18 years and \u2264 50 years\n* Pre-operative hemoglobin \\>8 g/dl\n* Willing to have buccal administration of misoprostol or a placebo at least one hour pre-procedure.\n* Ability to understand and the willingness to sign a written informed consent.\n* Admissible medical/surgical history\n* Can be previously treated with Depo-Lupron, Depo-Provera, or Oral Contraceptive pills\n* Intraoperative use of vasopressin and uterine tourniquet is permissible\n* Can have had prior Cesarean delivery\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 50 Years",
    "exclusionCriteria": "* Patients who have had a prior abdominal myomectomy\n* Post-menopausal women\n* Patients with known bleeding/clotting disorders\n* Patients with a history of gynecologic malignancy\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to misoprostol\n* Any cases converted to abdominal hysterectomy or other additional elective surgical procedures performed at time of abdominal myomectomy will be excluded from data analysis\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements."
}